Erik Wennerberg

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Epidermal Growth Factor Receptor

Small Cell Lung Cancer

Top Venues

Nature communications

Science translational medicine

Cancer immunology research

Science immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Nils-Petter Rudqvist, Maud Charpentier, Claire Lhuillier, Erik Wennerberg, Sheila Spada, Caroline Sheridan, Xi Kathy Zhou, Tuo Zhang, Sylvia C Formenti, Jennifer S Sims, Alicia Alonso, Sandra Demaria
Immunotherapy targeting different immune compartments in combination with radiation therapy induces regression of resistant tumors. Nature communications 14 (1) (2023)
John Stagg, Encouse Golden, Erik Wennerberg, Sandra Demaria
The interplay between the DNA damage response and ectonucleotidases modulates tumor response to therapy. Science immunology 8 (85) (2023)
Erik Wennerberg, Sumit Mukherjee, Sheila Spada, Clarey Hung, Christopher J Agrusa, Chuang Chen, Amanda Valeta-Magara, Nils-Petter Rudqvist, Samantha J Van Nest, Mohamed K Kamel, Abu Nasar, Navneet Narula, Vivek Mittal, Geoffrey J Markowitz, Xi Kathy Zhou, Prasad S Adusumilli, Alain C Borczuk, Thomas E White, Abdul G Khan, Paul J Balderes, Ivo C Lorenz, Nasser Altorki, Sandra Demaria, Timothy E McGraw, Brendon M Stiles
Expression of the mono-ADP-ribosyltransferase ART1 by tumor cells mediates immune resistance in non-small cell lung cancer. Science translational medicine 14 (636) (2022)
Maria Karasarides, Alexandria P Cogdill, Paul B Robbins, Michaela Bowden, Elizabeth M Burton, Lisa H Butterfield, Alessandra Cesano, Christian Hammer, Cara L Haymaker, Christine E Horak, Heather M McGee, Anne Monette, Nils-Petter Rudqvist, Christine N Spencer, Randy F Sweis, Benjamin G Vincent, Erik Wennerberg, Jianda Yuan, Roberta Zappasodi, Vanessa M Hubbard Lucey, Daniel K Wells, Theresa LaVallee
Hallmarks of Resistance to Immune-Checkpoint Inhibitors. Cancer immunology research 10 (4) (2022)